Femtech market seen reaching $37.24B by 2035

The global femtech market is projected to grow from $9.12 billion in 2025 to $37.24 billion by 2035, driven by digital women’s health adoption, AI personalization and telehealth. North America leads now, while Asia-Pacific is expected to grow fastest over the forecast period.

Why it matters: - Femtech is moving from a niche category into a broader women’s health market that spans fertility, pregnancy, nursing, menopause, pelvic health, contraception and wellness. - The forecast suggests growing demand for digital tools, connected devices and employer-backed benefits across consumer and clinical settings.

What happened: - Market Research Future estimated the global femtech market at $9.12 billion in 2025. - The market is projected to reach $37.24 billion by 2035. - The forecast implies a 15.10% compound annual growth rate from 2026 to 2035. - North America holds about 38.8% of global revenue. - Asia-Pacific is the fastest-growing region at a 16.20% CAGR. - The report was released Aug. 13, 2026. - Request a free sample - Read the detailed report

The details: - Digital women’s health adoption, investment in female-specific healthcare, connected devices, AI-driven personalization and telehealth are the main growth drivers. - Software is projected to grow at a 17.20% CAGR through 2035, making it the fastest-growing type. - Devices led the market with a 47.5% share in 2025, supported by wearables, connected breast pumps, pelvic-floor trainers and at-home hormone tests. - Services generated about $2.14 billion in 2025. - Pregnancy and nursing care held the largest application share at 28.9% in 2025. - Reproductive health and contraception generated about $2.25 billion in 2025. - Menstrual health management is projected to grow at 14.80% CAGR through 2035. - Pelvic and uterine health reached $0.72 billion in 2025. - Menopause and longevity is the fastest-growing application at 17.40% CAGR through 2035. - Hospitals and maternal centres led end users with a 42.5% share in 2025. - Specialty women’s health clinics are the fastest-growing end-user segment at 15.40% CAGR. - Home and direct-to-consumer sales totaled $1.92 billion in 2025. - Online retail is the key distribution channel for apps, connected devices, diagnostics and subscriptions. - Pharmacies and drugstores remain important for consumer health products and selected digital-health offerings.

Between the lines: - Venture capital commitments to women’s health startups exceeded $2.8 billion in 2024, showing continued investor interest in the category. - Policy attention to sex-disaggregated clinical data is helping support more female-specific product pipelines. - The market remains fragmented, with the top five players accounting for an estimated 28% to 34% of global revenue and an HHI below 1,000. - That fragmentation leaves room for startups and regional providers even as larger platforms build scale. - AI-enabled tools are likely to deepen engagement by combining historical health data with predictive models. - Employer-sponsored benefits could become a recurring demand source for fertility, maternity, menopause and family-health programs. - Regulatory harmonization may ease multi-market launches for software as a medical device and connected women's-health products.

What's next: - AI-driven platforms are expected to expand personalized fertility, pregnancy, menstrual and menopause care. - Connected devices are likely to feed more real-time data into digital care platforms. - Menopause is positioned as a major growth area as demand rises for symptom tracking, hormone management, telehealth and longevity services. - Corporate demand may also rise as firms use gender-health metrics and ESG reporting to justify femtech purchases. - More information on Market Research Future